Novo Nordisk reports 24% sales increase driven by diabetes and obesity treatments by Investing.comNovember 9, 20240 Investing.com — Novo Nordisk (NYSE:) (CSE:) reported strong growth for the first nine months of 2024, with revenue increasing 23%…